What the Elvie-Willow Deal Really Means for the Future of Femtech

A candid look at the risks, realities, and road ahead for women’s health innovation.

This isn’t our usual newsletter. Today’s issue breaks down one of the most significant shakeups in femtech to date: Willow’s acquisition of Elvie, a distressed sale that reveals deeper fault lines across the women’s health innovation landscape.

FemmeHealth Ventures Alliance is your trusted source for investor-grade insight into women’s health technology. Here’s what this deal tells us and what’s at stake.